Your Position: Home
> Coagulative Disorders Therapeutic Targets Coagulative Disorders Therapeutic Targets
| Protein Name | Alternative Names | BioChemical Class / Role | Products (Cat NO)![]() |
||
| Protein | Antibody | Gene cDNA clones | |||
| TPSB2 | TPS2, tryptaseB, tryptaseC | It comprise a family of trypsin-like serine proteases, the peptidase family S1, and fall into two groups, α and β. Tryptase is unique in two respects: it is enzymatically active only as a heparin-stabilized tetramer, and it is resistant to all known endogenous proteinase inhibitors because of the unique arrangement of the active sites. | 10505-H08H | HG10505-M | |
| Coagulation Factor X | F10,RP11-98F14.9, FX, FXA | It is an enzyme of the coagulation cascade. Apart from congenital deficiency, low factor X levels may occur occasionally in a number of disease states. Furhermore, factor X deficiency may be seen in amyloidosis, where factor X is adsorbed to the amyloid fibrils in the vasculature. | 11076-H08B | HG11076-M | |
| PAI-1/SerpinE1 | PAI, PAI1, PLANH1 | It is a secreted protein which belongs to the serpin family. SERPINE1 acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis. | 10296-H08H | HG10296-M | |
| Coagulation factor VII | FVII, F7 | It is a member of the peptidase S1 family, and is one of the central proteins in the coagulation cascade. The main role of factor VII is to initiate the process of coagulation in conjunction with tissue factor (TF). | 50034-M08C | HG11506-M, MG50034-M | |
+86-400-890-9989




